Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Hormel Foods Corp (HRL) Price & Performance

BridgeBio Pharma IncTrade
Hormel Foods CorpTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Hormel Foods Corp — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Hormel Foods Corp trades at $24.25 (market cap $13.37B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and Hormel Foods Corp pays a 4.81% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

BBIOHRL
Market Cap
$16.36B$13.37B
Sector
HealthConsumer Staples
52-Week High
$90.17$29.25
52-Week Low
$47.29$19.74
Enterprise Value
$18.14B$15.37B
Dividend Yield
4.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Hormel Foods Corp

Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.

Read more on HRL